Pheno Therapeutics aims to identify novel remyelinating agents and develop transformational therapeutics that enhance the repair of damaged myelin sheaths in Multiple Sclerosis patients. The company was founded by Advent Life Sciences and the University of Edinburgh to build on the ground breaking research of Prof Siddharthan Chandran and Prof Neil Carragher, world class experts in multiple sclerosis and stem cell biology, and phenotypic screening, respectively.
Location: United Kingdom, Scotland, City of Edinburgh
Employees: 1-10
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Advent Lif... | adventls.c... |
| - | Life Arc V... | lifearcven... |